Jim Sullivan

Jim Sullivan is the Chief Executive Officer at Vanqua Bio, where they have advanced over 100 compounds into clinical development across various disease states and technology platforms. With experience as a Venture Partner at OrbiMed and in multiple senior roles at AbbVie, they have a strong background in R&D within the Pharmaceutical and Biotech industries. Jim also served as an adjunct professor at Northwestern University and held positions at Abbott and Nova Pharmaceuticals early in their career. They earned a Ph.D. in Biochemistry from Trinity College Dublin.